This page includes the latest FDA filings for Udl Laboratories Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Cardinal Health, UDL Laboratories, Inc. | Prescription Medication | 2020-07-24 |
Cardinal Health | Prescription Medication | 2020-05-05 |
Cardinal Health | Prescription Medication | 2019-11-12 |
Cardinal Health, UDL Laboratories, Inc. | Prescription Medication | 2018-11-02 |
Cardinal Health, UDL Laboratories, Inc. | Prescription Medication | 2018-10-31 |
Cardinal Health, UDL Laboratories, Inc. | Prescription Medication | 2018-10-17 |
Cardinal Health | Prescription Medication | 2018-01-11 |
Cardinal Health, UDL Laboratories, Inc. | Prescription Medication | 2018-01-05 |
UDL LABORATORIES, INC. | BIOBRANE (R) II BLUE LABEL PRODUCT | 1991-02-22 |
UDL LABORATORIES, INC. | BIOBRANE | 1990-03-08 |
UDL LABORATORIES, INC. | BIOBRANE(R) II | 1989-10-20 |
NCAGE Code | 0EYU2 | UDL LABORATORIES INC |
NCAGE Code | 69945 | UDL LABORATORIES INC |
CAGE Code | 0EYU2 | UDL LABORATORIES INC |
CAGE Code | 69945 | UDL LABORATORIES INC |
SEC | 0001343802 | UDL Laboratories, Inc. of ILLINOIS |